Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Prattes, J; Giacobbe, DR; Bassetti, M; Gangneux, JP; Hoenigl, M, , POSACOVID, Study, Group.
Antifungal prophylaxis of COVID-19 associated pulmonary aspergillosis in ventilated patients: one solution does not fit all.
Intensive Care Med. 2024; 50(8):1375-1377
Doi: 10.1007/s00134-024-07542-0
Web of Science
PubMed
FullText
FullText_MUG
- Führende Autor*innen der Med Uni Graz
-
Prattes Jürgen
- Co-Autor*innen der Med Uni Graz
-
Hönigl Martin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Find related publications in this database (using NLM MeSH Indexing)
-
Humans - administration & dosage
-
COVID-19 - complications
-
Antifungal Agents - therapeutic use
-
Respiration, Artificial - adverse effects
-
Pulmonary Aspergillosis - administration & dosage
-
SARS-CoV-2 - administration & dosage